This study tests whether a special vaccine plus three lab-made antibodies can help people with HIV control the virus without taking daily antiretroviral therapy (ART). About 36 adults with well-controlled HIV will receive the vaccine and antibodies or a placebo, then temporarily …
Phase: PHASE1, PHASE2 • Sponsor: Boris Juelg, MD PhD • Aim: Disease control
Last updated May 19, 2026 11:59 UTC